Patient preference and acceptability of calcium plus vitamin D3 supplementation: a randomised, open, cross-over trial

Autor: Debby den Uyl, Frank N. R. van Berkum, Piet Geusens, Harry H.M.L. Houben, Max C. Jebbink, Willem F. Lems

Publikováno v: Clinical Rheumatology
Clinical Rheumatology, 29(5), 465-472. Springer London
den Uyl, D, Geusens, P P, van Berkum, F N, Houben, H H, Jebbink, M C & Lems, W F 2010, ' Patient preference and acceptability of calcium plus vitamin D3 supplementation: a randomised, open, cross-over trial ', Clinical Rheumatology, vol. 29, no. 5, pp. 465-472 . https://doi.org/10.1007/s10067-009-1328-3
Clinical Rheumatology, 29(5), 465-472. Springer-Verlag London Ltd.

Preference for a drug formulation is important in adherence to long-term medication for chronic illnesses such as osteoporosis. We investigated the preference for and acceptability of chewable tablet containing calcium and vitamin D (Calci Chew D-3,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb12129864b71430ce4d75412003ad4c
http://europepmc.org/articles/PMC2843840